Daiseki Co.,Ltd.
Daiseki Co.,Ltd. (DSKIF) Financial Performance & Income Statement Overview
Explore the financials of Daiseki Co.,Ltd. (DSKIF), including yearly and quarterly data on income, cash flow, and balance sheets.
Daiseki Co.,Ltd. (DSKIF) Income Statement & Financial Overview
Explore comprehensive income reports for Daiseki Co.,Ltd. DSKIF, broken down by year and quarter.
| Metric | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|
| Revenue | $17.27B | $17.24B | $16.09B | $16.70B |
| Cost of Revenue | $11.96B | $11.37B | $10.68B | $10.84B |
| Gross Profit | $5.31B | $5.87B | $5.41B | $5.86B |
| Gross Profit Ratio | $0.31 | $0.34 | $0.34 | $0.35 |
| R&D Expenses | $0.00 | $0.00 | $0.00 | $48.00M |
| SG&A Expenses | $2.12B | $2.07B | $1.99B | $1.91B |
| Operating Expenses | $2.12B | $2.07B | $1.99B | $1.96B |
| Total Costs & Expenses | $14.08B | $13.44B | $12.67B | $12.80B |
| Interest Income | $24.00M | $0.00 | $19.00M | $17.00M |
| Interest Expense | $9.00M | $0.00 | $9.00M | $7.00M |
| Depreciation & Amortization | $924.00M | $759.00M | $760.00M | $844.00M |
| EBITDA | $4.09B | $4.56B | $4.18B | $4.67B |
| EBITDA Ratio | $0.24 | $0.26 | $0.26 | $0.28 |
| Operating Income | $3.19B | $3.80B | $3.42B | $3.91B |
| Operating Income Ratio | $0.18 | $0.22 | $0.21 | $0.23 |
| Other Income/Expenses (Net) | -$36.00M | $42.00M | $65.00M | $287.00M |
| Income Before Tax | $3.15B | $3.84B | $3.49B | $4.19B |
| Income Before Tax Ratio | $0.18 | $0.22 | $0.22 | $0.25 |
| Income Tax Expense | $944.00M | $1.23B | $1.11B | $1.31B |
| Net Income | $2.02B | $2.41B | $2.19B | $2.69B |
| Net Income Ratio | $0.12 | $0.14 | $0.14 | $0.16 |
| EPS | $41.98 | $50.11 | $45.71 | $55.53 |
| Diluted EPS | $41.98 | $50.11 | $45.71 | $55.53 |
| Weighted Avg Shares Outstanding | $48.04M | $48.05M | $48.003M | $48.38M |
| Weighted Avg Shares Outstanding (Diluted) | $48.04M | $48.05M | $48.003M | $48.38M |
Over the past four quarters, Daiseki Co.,Ltd. demonstrated steady revenue growth, increasing from $16.70B in Q1 2024 to $17.27B in Q4 2024. Operating income reached $3.19B in Q4 2024, maintaining a consistent 18% margin over recent quarters. Despite fluctuations in R&D and SG&A expenses, EBITDA remained robust at $4.09B, reflecting operational efficiency. Net income dropped to $2.02B, with EPS at $41.98. Disciplined expense management helped sustain profitability, highlighting solid overall financial performance.
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan